NCT05968378

Brief Summary

This study will assess the impact of 8-hour time restricted eating (8 hours of eating, 16 hours fasting) combined with a Mediterranean diet on metabolism and inflammation in adults with non-alcoholic fatty liver disease (NAFLD).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

June 26, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

1 year

First QC Date

June 26, 2023

Last Update Submit

July 26, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in plasma inflammatory response to a high-fat meal: C-reactive protein (CRP)

    Postprandial changes in CRP (mg/L) will be measured in response to a high-fat meal

    To be assessed at baseline and post 8-week intervention

  • Change in plasma inflammatory response to a high-fat meal: Interleukin-6 (IL-6)

    Postprandial changes in IL-6 (pg/mL) will be measured in response to a high-fat meal

    To be assessed at baseline and post 8-week intervention

  • Change in plasma inflammatory response to a high-fat meal: Interleukin-1-beta (IL-1β)

    Postprandial changes in IL-1β (pg/mL) will be measured in response to a high-fat meal

    To be assessed at baseline and post 8-week intervention

  • Change in plasma inflammatory response to a high-fat meal: Tumor necrosis factor alpha (TNF-α)

    Postprandial changes in (TNF-α) (pg/mL) will be measured in response to a high-fat meal

    To be assessed at baseline and post 8-week intervention

Secondary Outcomes (20)

  • Change in metabolic response to a high-fat meal: Glucose

    To be assessed at baseline and post 8-week intervention

  • Change in metabolic response to a high-fat meal: Insulin

    To be assessed at baseline and post 8-week intervention

  • Change in metabolic response to a high-fat meal: Glucagon

    To be assessed at baseline and post 8-week intervention

  • Change in metabolic response to a high-fat meal: Triglycerides

    To be assessed at baseline and post 8-week intervention

  • Change in metabolic response to a high-fat meal: Non-esterified fatty acids (NEFA)

    To be assessed at baseline and post 8-week intervention

  • +15 more secondary outcomes

Study Arms (2)

Standard healthy eating advice

ACTIVE COMPARATOR

Subjects in this group will be counselled according to the Irish National Healthy Eating Guidelines.

Behavioral: Standard healthy eating advice

eTRE plus Mediterranean diet

EXPERIMENTAL

Subjects in this group will be asked to restrict their eating to 8-hours daily (8am - 4pm) and to adhere to a Mediterranean style diet.

Behavioral: eTRE plus Mediterranean diet

Interventions

Subjects in this group will be provided with standard healthy eating advice according to the Irish National Healthy Eating Guidelines and Food Pyramid and will be asked to follow this advice for 8-weeks.

Standard healthy eating advice

Subjects in this group will be asked to consume all meals between 8am - 4pm and to adhere to a Mediterranean style diet daily for 8-weeks.

eTRE plus Mediterranean diet

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females
  • Age 18-65 years, from all ethnic groups, capable of providing informed consent to participate
  • Obesity (body mass index \>30kg/m\^2) and of stable body weight (±3% for ≥3 months)
  • Fasting blood glucose \<7.0 mmol/L and HbA1c \<6.5%.
  • Liver fat \>10% (CAP score \>238 dB/m) and no fibrosis (liver stiffness score 2-7 kPa) as assessed by liver elastography (FibroScan)

You may not qualify if:

  • Impaired renal function
  • Abnormal hematocrit
  • History of cardiovascular events
  • Uncontrolled hypertension
  • Type 2 diabetes
  • Medications or supplements known to affect glucose or lipid metabolism
  • Active inflammatory, autoimmune, infectious, gastrointestinal, or malignant disease
  • Uncontrolled neurological or psychiatric disease
  • Iron deficiency anemia, (hemoglobin \< 12g/dl men, \< 11g/dl women)
  • Fatty acid supplements and consumers of high doses of anti- antioxidant vitamins (A, C, E, b-carotene)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College Dublin

Dublin, Leinster, D04 V1W8, Ireland

RECRUITING

MeSH Terms

Conditions

Non-alcoholic Fatty Liver DiseaseFatty LiverObesityInflammation

Interventions

Diet, Mediterranean

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Helen M Roche, Professor

CONTACT

Christopher E Shannon, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2023

First Posted

August 1, 2023

Study Start

June 1, 2023

Primary Completion

June 1, 2024

Study Completion

July 1, 2024

Last Updated

August 1, 2023

Record last verified: 2023-07

Locations